Market Research Logo

Quanterix Corporation - Product Pipeline Analysis, 2016 Update

Summary

Quanterix Corporation (Quanterix) is a medical device manufacturer that develops ultra-sensitive diagnostic platform for measuring individual proteins. The company’s products include simoa HD1 analyzer, assay kits and consumables. It provides assay kits including C-peptide simoa assay kit, homebrew assay kit, homebrew bead and SBG kit, PSA Simoa assay kit, tau simoa assay kit and TNF-a simoa assay kit. Quanterix's products find application in life sciences research, oncology, neurology, inflammatory disease and infectious disease areas. The company also partners with other companies to develop and validate bioassays. Quanterix is headquartered in Lexington, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Quanterix Corporation
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


Quanterix Corporation Company Snapshot
Quanterix Corporation Company Overview
Quanterix Corporation Pipeline Products and Clinical Trials Overview
Quanterix Corporation – Pipeline Analysis Overview
Key Facts
Quanterix Corporation - Major Products and Services
Quanterix Corporation Pipeline Products by Development Stage
Quanterix Corporation Pipeline Products Overview
AccuPSA Test
AccuPSA Test Product Overview
Antigen Detection Assay - Tuberculosis
Antigen Detection Assay - Tuberculosis Product Overview
Blood Test – Concussions/TBI
Blood Test – Concussions/TBI Product Overview
Diagnostic Assay - Alzheimer’s Disease
Diagnostic Assay - Alzheimer’s Disease Product Overview
Digital ELISA - Crohn’s Disease
Digital ELISA - Crohn’s Disease Product Overview
Digital ELISA Assay - C. Difficile
Digital ELISA Assay - C. Difficile Product Overview
POC Device - Neurological Injuries
POC Device - Neurological Injuries Product Overview
Simoa 3.0
Simoa 3.0 Product Overview
Simoa 4.0
Simoa 4.0 Product Overview
Simoa 5.0
Simoa 5.0 Product Overview
SiMoA HD-1 Analyzer - Botulinum Toxin Assay
SiMoA HD-1 Analyzer - Botulinum Toxin Assay Product Overview
SiMoA HD-1 Analyzer - Prostate Cancer Assay
SiMoA HD-1 Analyzer - Prostate Cancer Assay Product Overview
Quanterix Corporation - Key Competitors
Quanterix Corporation - Key Employees
Quanterix Corporation - Locations And Subsidiaries
Head Office
Recent Developments
Quanterix Corporation, Recent Developments
Jun 15, 2016: Frontage Laboratories Announces Partnership with Quanterix and Validation of Simoa HD-1 Analyzer and Software to Support Biomarker Analysis
Apr 18, 2016: Quanterix Opens Call for Proposals for Second Annual Accelerator Grant Program Focused on Oncology and Liquid Tumor Biopsy Technology
Mar 03, 2016: Quanterix’s Single Molecule Array Technology Unlocks New Biomarker Fueling Advancements in Neurological Research
Feb 10, 2016: Quanterix Names Frontage Laboratories as a Preferred Partner in Biomarker Assay Development and Testing Services in the Regulated Space
Feb 05, 2016: Quanterix Presented Ultrasensitive Technology at NFL Health and Safety Update & Interactive Head Health Showcase
Jan 27, 2016: Quanterix Announces Expansion into Asia Pacific
Jan 14, 2016: ABL Offers Quanterix Diagnostic Platform for Ultrasensitive Biomarker Detection Through Platine Pharma Services Subsidiary
Nov 17, 2015: Quanterix’s Ultrasensitive Single Molecule Measurement Technology Featured in Clinical Chemistry
Oct 28, 2015: Quanterix Launches Next Generation Simoa 2.0 Ultrasensitive Immunoassay Platform
Aug 26, 2015: Researchers Use Quanterix’s Simoa Technology to Detect Early Indicators of Potential Adverse Cardiovascular Outcomes
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Quanterix Corporation Pipeline Products and Clinical Trials Overview
Quanterix Corporation Pipeline Products by Equipment Type
Quanterix Corporation Pipeline Products by Indication
Quanterix Corporation, Key Facts
Quanterix Corporation, Major Products and Services
Quanterix Corporation Number of Pipeline Products by Development Stage
Quanterix Corporation Pipeline Products Summary by Development Stage
AccuPSA Test - Product Status
AccuPSA Test - Product Description
Antigen Detection Assay - Tuberculosis - Product Status
Antigen Detection Assay - Tuberculosis - Product Description
Blood Test – Concussions/TBI - Product Status
Blood Test – Concussions/TBI - Product Description
Diagnostic Assay - Alzheimer’s Disease - Product Status
Diagnostic Assay - Alzheimer’s Disease - Product Description
Digital ELISA - Crohn’s Disease - Product Status
Digital ELISA - Crohn’s Disease - Product Description
Digital ELISA Assay - C. Difficile - Product Status
Digital ELISA Assay - C. Difficile - Product Description
POC Device - Neurological Injuries - Product Status
POC Device - Neurological Injuries - Product Description
Simoa 3.0 - Product Status
Simoa 3.0 - Product Description
Simoa 4.0 - Product Status
Simoa 4.0 - Product Description
Simoa 5.0 - Product Status
Simoa 5.0 - Product Description
SiMoA HD-1 Analyzer - Botulinum Toxin Assay - Product Status
SiMoA HD-1 Analyzer - Botulinum Toxin Assay - Product Description
SiMoA HD-1 Analyzer - Prostate Cancer Assay - Product Status
SiMoA HD-1 Analyzer - Prostate Cancer Assay - Product Description
Quanterix Corporation, Key Employees
List of Figures
Quanterix Corporation Pipeline Products by Equipment Type
Quanterix Corporation Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report